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inflammatory joint disease. In this study we investigated the role 
of TLR-4 in human articular chondrocytes. 
Methods: The presence of TLR-4 in human articular cartilage 
was assessed by RT-PCR and Western immunoblotting. Articu- 
lar chondrocytes were isolated from human donors and TLR-4 -/- 
mice and grown as monolayer cultures. Chondrocytes were stim- 
ulated with LPS, Interleukin(IL)-ll~ and osteogenic protein(OP)- 
1. Proteoglycan-synthesis was measured by [35S]Sulfate incor- 
poration into newly synthesized macromolecules. The endoge- 
nous gene expression of cartilage markers as well as IL-11~ was 
examined using RT-PCR. The phosphorylation of signalling ki- 
nases, induced by LPS-stimulation was investigated by Western- 
immunoblotting. 
Results: The expression of TLR-4 in human articular chondro- 
cytes was detected on the mRNA level and on the protein level. 
The stimulation with LPS, the ligand of the CD14/TLR-4 recep- 
tor complex, resulted in a decrease in total proteoglycan synthe- 
sis, while in TLR-4 -/- mice no such effect could be seen. IL-11~ 
mRNA expression was increased by TLR incubation, simultane- 
ously, aggrecan expression was significantly decreased. The co- 
stimulation with OP-1 and LPS antagonized the catabolic effects 
of LPS. The LPS-induced endogenous expression of IL-11~ was 
inhibited by blocking NFkB. 
Conclusion: Our data demonstrated that LPS exerts its catabolic 
effects in articular cartilage in the presence of TLR-4. The LPS- 
induced decrease in proteoglycan synthesis could be counter- 
acted by OP-1. Furthermore, NFkB may play an important role in 
TLR-4 signalling. Taken together, the presence and activation of 
TLR-4 in articular cartilage may contribute to the degradation of 
cartilaginous tissue in inflammatory joint diseases. 
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Aims: Restoration of joint homeostasis is an important therapeu- 
tic goal in arthritis. Increasing evidence supports a role for em- 
bryonic signaling pathways such as Bone Morphogenetic Pro- 
teins (BMPs) and Wnts in postnatal tissue homeostasis. BMPs 
have been associated with tissue repair responses to inflamma- 
tion/injury whereas functional variants in Frzb, a Wnt antagonist 
expressed in developing and adult cartilage have been linked 
to hip osteoarthritis. We investigated the role of BMP and Wnt 
signaling in articular cartilage homeostasis in mouse models of 
inflammation-driven a d degenerative joint disease. 
Methods: Methylated BSA arthritis was induced in heterozygous 
mice with a targeted inactivation of the noggin gene and insertion 
of a b-gal reporter (noggin +/Lacz) by intra-articular mBSA injec- 
tion on day 1, injection of subcutaneous IL-1 on 3 consecutive 
days and sacrificed at day 7. Severity of disease was determined 
by histology. In additional experiments, intra-articular adenoviral 
noggin overexpression was studied. The Frizzled related Protein- 
3 gene (sFRP3, the mouse homologue of Frzb) was inactivated 
by excision of its first coding exon. OA was induced by intra- 
articular injection of collagenase type VII or papain. Mice were 
sacrificed after 7 and 21 days. The extent of OA was evaluated 
by histology. Cartilage damage in both models was measured by 
digital image analysis using safranin O to quantify proteoglycan 
content. 
Results: The histological severity of mBSA monoarthritis in 
noggin +/Lacz mice was similar to that of wild type mice with the 
exception that synovial cell infiltration was significantly higher in 
noggin +/Lacz mice. Cartilage destruction was significantly reduced 
in noggin +/Lacz mice suggesting a protective role for BMP signal- 
ing (p<0.006). In contrast adenoviral overexpression of noggin 
resulted in significantly higher proteoglycan loss as compared to 
wildtype mice (p<0.05). SFRP3 -/- were viable without overt phe- 
notype during development and normal growth. Both sFRP3-/-and 
wildtype mice showed typical features of osteoarthritis after colla- 
genase or papain injections. No differences in synovial inflamma- 
tion and fibrosis were seen between sFRP3 -/- and wildtype mice 
7 days and 21 days. In contrast, articular cartilage proteoglycan 
loss was significantly greater in sFRP3 -/- than in wildtype mice 7 
days after papain (p < 0.05) or 21 days after collagenase treat- 
ment (p<0.05). 
Conclusion: BMP and Wnt signaling likely play an opposite role 
in joint cartilage homeostasis. Shifting the balance in BMP sig- 
naling by reducing levels of noggin, provides protection for the 
articular cartilage against inflammation-driven destruction. Con- 
versely, antagonist over-expression renders the cartilage more 
vulnerable. Accelerated cartilage loss in sFRP3-/-mice suggests 
that Wnt signaling has a negative effect on the maintenance of 
articular cartilage homeostasis whereas Wnt antagonists appear 
to be chondroprotective. 
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Aim: To determine the effect of IL-6, and its soluble receptor, on 
the production of type II collagen by rabbit articular chondrocytes 
(RAC) and the molecular mechanisms whereby IL-6/slL-6R mod- 
ulate the transcription of COL2A1. 
Methods: Collagen synthesis was assayed by [3H]proline label- 
ing and the bacterial collagenase method. RAC were treated with 
5 to 100 ng/ml hreclL-6, hrec slL-6R or both. Western blotting for 
type II collagen, Spl and Sp3, was performed on extracts from 
cells treated or not with 10 or 25 ng/ml I L-6, sl L-6R or both. Type 
II collagen, Spl and Sp3 protein levels were normalized to I~-actin 
protein signal. RNA was reverse transcribed to cDNA, which was 
then subjected to real-time PCR (Q-RT-PCR), for type II collagen, 
Spl and Sp3 mRNA levels. Data were normalized with 18S RNA 
and gene expression was calculated with the ddCt method. RAC 
were also transfected with COL2Al-luciferase reporter vectors 
and pSV401~-gal plasmid. In some experiments, reporter plasmids 
were also cotransfected with Spl and/or the full lengh Sp3 ex- 
pression vectors. The corresponding plasmids were used as con- 
trols (pEVR2/Spl and/or pN3). 10-15 h later, the medium was 
changed to 10% FCS/DMEM with IL-6, slL-6R or both. After 24 
h, protein content, luciferase and I~-galactosidase activities were 
determined. For decoy, RAC were transfected with double-strand 
oligonucleotides which interfere with Spl and Sp3 DNA binding 
within the 63-bp short promoter. A multicopy of the -50/+1 wild 
type (wt) and mutant sequence found in the COL2A1 promoter 
were used. 10-15 h after transfection, the medium was changed 
to fresh medium containing the decoy oligonucleotides and cell 
cultures were incubated for a further 24-h period with IL-6, slL- 
6R, or both. Nuclear extracts were also prepared and EMSA were 
performed. 
Results: IL-6, slL-6R and IL-6/slL-6R down-regulated the pro- 
duction of type II collagen, through type II collagen mRNA de- 
crease. Transient co-transfection of human COL2A1 gene con- 
structs, containing deletions in both promoter and/or first intron 
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regions, suggested that the -63/-35 sequence of COL2A1 pro- 
moter, which binds Spl and Sp3 transcription factors, is involved 
in this repression. IL-6, slL-6R, or their association, reduced the 
levels of Spl mRNA and enhanced those of Sp3 mRNA, whereas 
they inhibit Spl and Sp3 protein expression. The -50/+1 se- 
quence of COL2A1 could act as a decoy oligonucleotide, pre- 
venting the I L-6/slL-6R inhibition of the 63-bp COL2A 1 proximal 
promoter transcription. By contrast, the related oligonucleotide, 
mutated in the binding site of Spl/Sp3, did not abolish the nega- 
tive effect of the cytokine and/or its soluble receptor. 
Conclusions: Spl is a strong activator of COL2A1 gene expres- 
sion via the -63/+1 region, whereas the overexpression of Sp3 
blocks the Spl up-regulation of the COL2A 1 promoter activity. We 
can conclude that IL-6, slL-6R, or both, decrease the Spl /Sp3 ra- 
tio and inhibit the type II collagen gene expression. 
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Aim of the study: To unravel the role of suppressor of cytokine 
signaling (SOCS)3 in the induction of chondrocyte desensitiza- 
tion towards its main anabolic factor, insulin like growth factor 
(IGF)-I. 
Methods: Chondrocyte responsiveness to IGF-1 was assessed 
by 35S-sulphate incorporation into proteoglycans (PG)s, aggre- 
can m RNA expression using RT-QPCR, and insulin-receptor sub- 
strate (IRS)-I tyrosine phosphorylation (westernblot). IGF-1 de- 
sensitization of murine patellar chondrocytes was studied in 
zymosan-induced arthritis (ZIA). IGF -1 desensitization was in- 
duced in patellar cartilage explants or murine H4 chondrocyte cell 
line, exposed to I L-I~. SOCS3 protein expression was assessed 
by immunohistochemistry or by westernblot analysis of protein 
extracts. The role of SOCS3 in IGF-1 signaling was elucidated by 
adenoviral overexpression. 
Results: Exposure of murine articular cartilage to IL-1 almost 
completely blocked the IGF-1 induced PG synthesis and this ef- 
fect could not be prevented by the addition of inducible nitric-oxide 
synthase (iNOS) inhibitors (NIO, LNMA). Also on patellae taken 
from iNOS -/- mice did IL-1 induce chondrocyte IGF-1 responsive- 
ness. Next we investigated the role of SOCS proteins as these 
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Fig. 1. IL- 1-induced suppression of chondrocyte aggrecan mRNA expression 
and IGF-1 desensitization coincides with SOCS3 expression. H4 chondro- 
cytes were cultured for eight hours in the presence of IGF (250 ng/ml) or a 
combination between IGF-1 and IL-1 (10 ng/ml). Thereafter total RNA was 
extracted using Trizol method and mRNA expression levels for SOCS3 and 
Aggrecan were determined using RT-QPCR. mRNA levels were normalized 
against GAPDH mRNA levels and quantitative analysis was performed after 
35 PCR cycles and presented as a percentage of control. 
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Fig. 2. SOCS3 overexpression i duces IGF-1 nonresponsiveness of chon- 
drocytes. H4 chondrocytes were either infected using Ad5 luciferase or in- 
fected with the adenoviral vector containing the murine SOCS3 gene at a 
multiplicity of infection (MOI) of 50. SOCS3 overexpression significantly in- 
hibited IGF-1 induced stimulation of aggrecan mRNA induction. Aggrecan 
mRNA expression levels were corrected for the house-hold gene GAPDH 
and normalized for the basal aggrecan mRNA expression levels. SOCS3 
overexpression followed by IL-1 addition resulted in an almost complete in- 
hibition of aggrecan expression by H4 articular chondrocytes. Data are pre- 
sented as means ± SE, **p < 0.01 using Student's t-test. 
are negative feedback regulators of signal transducer and acti- 
vators of transcription (STAT) and are implicated in growth factor 
responses. In H4 chondrocytes we showed that IL-1 significantly 
up-regulated SOCS3 transcription and at the same time reduced 
aggrecan transcription (Fig. 1 ). In contrast, IL-18 was unable to in- 
duce SOCS3 expression and failed to induce chondrocyte IGF-1 
desensitization. Histology from arthritic knee joints revealed high 
expression of SOCS3 in chondrocytes. By adenoviral gene trans- 
fer of SOCS3 we obtained direct evidence that SOCS3 inhibits 
IGF-1 -stimulated aggrecan expression (Fig. 2) and IRS-1 tyrosine 
phosphorylation. The IGF-1 desensitization by forced SOCS3 ex- 
pression was comparable to the observed IL-1 effect on these H4 
chondrocytes. 
Conclusions: In the present study we show that IL-1 induced 
SOCS3 expression is a novel mechanism of IGF-1 desensitiza- 
tion in chondrocytes, and together with nitric-oxide it can con- 
tribute to cartilage damage during arthritis. 
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Introduction: Osteoarthritis is a common joint disease, mainly 
effecting the elderly population. With age an imbalance between 
catabolic and anabolic factors is observed which might be related 
with OA development. Old mice show a poor response to the an- 
abolic factor TGF-beta in counteraction of the catabolic factor IL- 
l .  We hypothesize that TGF-beta signaling is reduced with age 
and assessed the functional consequence of diminished TGF- 
beta signaling for cartilage repair. 
Methods: Knee joints were isolated of mice aged 5 months or 
2 years. Half of the mice were injected with IL-1 intra-articularly 
24 hours prior to knee joint isolation. Immunohistochemistry was 
performed staining for TGF-betal,  -2 or -3, TGF-betaRI, or -RII, 
Smad2, -3, -4, -6, -7 and Smad-2P. We determined the percent- 
age of cells in tibial cartilage that stained positive for the vari- 
ous TGF-beta signaling components with a computerized imag- 
ing system. 
To mimic the TGF-beta deprivation in old mice we injected young 
